Literature DB >> 17597683

Bone mineral density in patients with femoral neck fractures.

Krzysztof Olszewski1, Dorota Olszewska-Słonina, Dariusz Matewski, Jacek Kruczyński.   

Abstract

BACKGROUND: [corrected] By providing essential information regarding bone mineral density (BMD), Densitometry can predict the mechanical resistance of bone tissue and the risk of fractures. However, fractures frequently occur in the femoral cervix and the spine before the loss of BMD reaches the densitometric threshold of osteoporosis.
MATERIAL AND METHODS: We studied 46 patients with total hip arthroplasty subsequent to femoral cervix fracture, divided into three age groups: 80. All subjects underwent densitometry of the unaffected hip and the spine. BMD was also measured in slices of resected bone taken from various points.
RESULTS: 80.4% of the patients with fractures were women. The BMD of the femoral cervix and the lumbar spine is lower in women regardless of age. Even though the men in the 70-79 age bracket had the highest BMD in both places, their T-score for the femoral cervix indicated osteoporosis; as did that of all subjects in the 80+ age group. The remaining patients should be diagnosed with osteopenia. The in vitro results were similar.
CONCLUSIONS: The lower average BMD in all women points to a significantly higher risk of fracture. Reduced BMD indicates risk but is not a certain predictor of fracture. This may result from uneven distribution of bone density in the femoral cervix. The fact that lower BMD was found in slices from the anterior and inferior regions of the femoral cervix, lying on the axis of greatest distortion during a fall, may support this hypothesis.

Entities:  

Year:  2006        PMID: 17597683

Source DB:  PubMed          Journal:  Ortop Traumatol Rehabil        ISSN: 1509-3492


  1 in total

1.  Analysis of kyphosis, vertebral fracture and bone mineral density measurement in women living in nursing homes.

Authors:  Ayla C Turk; Fusun Sahın; Ferıt K Kucukler; Hulya Devecı
Journal:  Saudi Med J       Date:  2018-07       Impact factor: 1.484

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.